Please login to the form below

Not currently logged in
Email:
Password:

Xiaflex

This page shows the latest Xiaflex news and features for those working in and with pharma, biotech and healthcare.

Endo tries to ride out Valeant with $15.7bn bid for Salix

Endo tries to ride out Valeant with $15.7bn bid for Salix

a $2.6bn deal that added specialty medicine Xiaflex for fibrotic conditions affecting the fingers and penis. .

Latest news

  • Endo to acquire Auxilium for $2.6bn Endo to acquire Auxilium for $2.6bn

    Auxilium's lead product is Xiaflex (collagenase clostridium histolyticum), which is approved in Europe for the treatment of Dupuytren's contracture, a condition that causes one or more fingers to bend ... We intend to leverage Auxilium's leading presence

  • Endo's $2.2bn bid for Auxilium Pharma could thwart QLT deal Endo's $2.2bn bid for Auxilium Pharma could thwart QLT deal

    Auxilium has 12 approved products in its portfolio, including a range of testosterone supplements headed by Testim Gel, as well as Xiaflex (collagenase clostridium histolyticum) for Dupuytren's contracture - a condition ... While Auxilium's entire

  • Auxilium's Xiaflex cleared in US for erection disorder Auxilium's Xiaflex cleared in US for erection disorder

    FDA approval to treat Peyronie's disease. The US Food and Drug Administration (FDA) cleared Auxilium Pharmaceutical's Xiaflex product to treat Peyronie's disease, a condition that causes painful curvature ... The company has since signed a deal with

  • Extending the arsenal

    XIAFLEX (Auxilium Pharmaceuticals). Dupuytren's contracture. US. Capsaicin dermal patch. Qutenza (NeurogesX).

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....

Infographics